AcquisitionOther
22nd Century Group, Inc. acquired GVB Biopharma,
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
22nd Century Group, Inc. -> GVB Biopharma, · $4.5 million
The combination with 22 nd Century establishes a global one-of-a-kind asset to serve the rapidly growing hemp/cannabis ingredient market.
Open source record (SEC) ↗